Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-18T14:58:49.108Z Has data issue: false hasContentIssue false

Antidepressant-associated mania with escitalopram

Published online by Cambridge University Press:  16 April 2020

Michael Prapotnik*
Affiliation:
Department of Psychiatry I, Regional Hospital Rankweil, Valdunastr. 16, 6830Rankweil, Austria
Jan Di Pauli
Affiliation:
Department of Psychiatry I, Regional Hospital Rankweil, Valdunastr. 16, 6830Rankweil, Austria
Zeynep Vetter
Affiliation:
Department of Psychiatry I, Regional Hospital Rankweil, Valdunastr. 16, 6830Rankweil, Austria
Peter König
Affiliation:
Department of Psychiatry I, Regional Hospital Rankweil, Valdunastr. 16, 6830Rankweil, Austria
Andreas Conca
Affiliation:
Department of Psychiatry I, Regional Hospital Rankweil, Valdunastr. 16, 6830Rankweil, Austria
Roland Waschgler
Affiliation:
Medical Central Laboratory, Carinag. 41, 6800Feldkirch, Austria
*
*Corresponding author. Email addresses:michael.prapotnik@lkhr.at

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the editor
Copyright
Copyright © European Psychiatric Association 2004

References

Barak, Y, Kimhi, R, Weizman, R. Is electivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients? Int. Clin. Psychopharmacol. 2000;15(1):53-6.CrossRefGoogle Scholar
Bryois, C, Ferrero, F. Mania induced by citalopram. Arch. Gen. Psychiatry 1994;51(8):664-5.CrossRefGoogle ScholarPubMed
Devanand, D.P, Sackeim, H.A, Decina, P, Prudic, JThe development of mania and organic euphoria during ECT. J. Clin. Psychiatry 1988;49(2):69-71.Google ScholarPubMed
Owens, M.J, Knight, D.L, Nemeroff, C.BSecond-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol. Psychiatry 2001;50(5):345-50.CrossRefGoogle ScholarPubMed
Rochat, B, Amey, M, Baumann, PAnalysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography. Ther. Drug Monit. 1995;17(3):273-9.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.